• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13D filed by Hexindai Inc.

    8/2/21 4:30:19 PM ET
    $HX
    Finance: Consumer Services
    Finance
    Get the next $HX alert in real time by email
    SC 13D 1 ea145111-13dwebao_xiaobai.htm SCHEDULE 13D

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

     

    SCHEDULE 13D

     

    Under the Securities Exchange Act of 1934

     

     

     

    Xiaobai Maimai Inc.

    (Name of Issuer)

     

     

     

    Ordinary Shares, $.0001 par value

    (Title of Class of Securities)

     

    98422P108

    (CUSIP Number)

     

    Webao Limited12 / F, Santai building

    137-139 Connaught Road Central

    Hong Kong

    Telephone: +852085265538426

    (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

     

    with a copy to:

    Hunter Taubman Fischer & Li LLC

    800 Third Avenue, Suite 2800

    New York, NY 10022 Attention: Joan Wu

    Telephone: +1 (212) 530-2208

     

    July 13, 2021

    (Date of Event which Requires Filing of this Statement)

     

     

     

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. ☐

     

    Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.

     

    * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

     

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

     

     

      

    1

    NAMES OF REPORTING PERSONS:

    Webao Limited

     

    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY):

    N/A

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS):

     

    (a) ☐

    (b) ☐

    3

    SEC USE ONLY:

     

    4

    SOURCE OF FUNDS (SEE INSTRUCTIONS):

     

    WC

    5

    CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e): ☐

     

    6

    CITIZENSHIP OR PLACE OF ORGANIZATION:

     

    Hong Kong

     

     

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

    7

    SOLE VOTING POWER:

     

    0

    8

    SHARED VOTING POWER:

     

    31,980,800

    9

    SOLE DISPOSITIVE POWER:

     

    0

    10

    SHARED DISPOSITIVE POWER:

     

    31,980,800

    11

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:

     

    31,980,800

    12

    CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS): ☐

     

    13

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11):

     

    60.96% *

    14

    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS):

     

    OO

     

    *Percentage is calculated based on 52,458,550 ordinary shares outstanding as of July 28, 2021, including 2,442,093 ordinary shares issued to the depositary of the Issuer and reserved for future exercise of awards to be granted under the Issuer’s Amended and Restated 2016 Equity Incentive Plan.

     

    2

     

     

    Item 1. Security and Issuer 

     

    Securities acquired: Ordinary Shares, par value $0.0001 per share
       
    Issuer:

    Xiaobai Maimai Inc.

    Room 515, Floor 5, Jia No. 92-4 to 24 Jianguo Road

    Chaoyang District, Beijing 100020

    People’s Republic of China

     

    Item 2. Identity and Background

     

    (a)-(b) This Schedule 13D is filed by Webao Limited. Webao Limited is hereinafter referred to as a “Reporting Person.”

     

    The principal place of business of the Reporting Person is 12 / F, Santai building, 137-139 Connaught Road Central, Hong Kong.

     

    (c) The Reporting Person is primarily involved in investment activities.

     

    (d) During the last five years, the Reporting Person has not been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).

     

    (e) During the last five years, the Reporting Person has not been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and, as a result of such proceeding, was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

     

    (f) The Reporting Person is organized under the laws of Hong Kong.

     

    Item 3. Source and Amount of Funds or Other Consideration.

     

    On July 13, 2021, the Reporting Person acquired 31,980,800 ordinary shares of the Issuer in a private transaction pursuant to a Share Purchase Agreement dated July 2, 2021, by and between the Reporting Person and Hexin Holding Limited.

     

    Item 4. Purpose of Transaction.

     

    The Reporting Person acquired the shares for investment purposes in the belief that the shares represent an attractive investment opportunity. The Reporting Person intends to review its investment in the Issuer on a continuing basis. Representatives of the Reporting Person may have discussions from time to time with the Issuer, other shareholders and third parties relating to the Issuer, strategic alternatives that may be available to the Issuer and the Issuer’s business, operations, assets, capitalization, financial condition, governance, management and future plans, including in respect of one or more of the actions described in subsections (a) through (j) of Item 4 of Schedule 13D of the Act. There can be no assurance as to the outcome of any of the discussions referred to in this Schedule 13D.

     

    Depending on various factors, including the Issuer’s financial position and strategic direction, the outcome of the discussions referenced above, actions taken by the board of directors of the Issuer, price levels of the securities of the Issuer, other investment opportunities available to the Reporting Person, the availability and cost of debt financing, the availability of potential business combination and other strategic transactions, conditions in the capital markets and general economic and industry conditions, the Reporting Person may in the future take such actions with respect to its investments in the Issuer as it deems appropriate, including acquiring or disposing of securities of the Issuer, entering into financial instruments or other agreements which increase or decrease the Reporting Person’s economic exposure with respect to its investments in the Issuer, engaging in any hedging or similar transactions with respect to such holdings and/or otherwise changing its intention with respect to any and all matters referred to in Item 4 of Schedule 13D of the Act.

     

    Except as set forth in this Item 4 or Item 6 below, the Reporting Person has no present plans or proposals that relate to or that would result in any of the actions specified in clauses (a) through (j) of Item 4 of Schedule 13D of the Act.

     

    3

     

     

    Item 5. Interest in Securities of the Issuer.

     

      (a)-(b) The responses to Items 7 - 13 of the cover pages of this Schedule 13D are incorporated herein by reference.

     

    The Reporting Person is controlled by its board of directors. Any action by the Reporting Person with respect to the issuer or the Issuer’s securities held by the Reporting Person, including voting and dispositive decisions, requires at least a majority vote of the board of directors. Under the so-called “rule of three,” because voting and dispositive decisions are made by at least a majority of the board of directors, none of the directors is deemed to be a beneficial owner of the Issuer’s securities held by the Reporting Person. The filing of this statement shall not be construed as an admission that any such person or individual described herein is, for the purpose of Section 13(d) or 13(g) of the Act, the beneficial owner of any securities covered by this statement.

     

      (c) Other than the acquisition of the shares as reported in this Schedule 13D, no actions in the ordinary shares of the Issuer were effected during the past sixty (60) days by the Reporting Person.

     

      (d) None

     

      (e) N/A

     

    Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.

     

    Other than the foregoing agreements and arrangements, there are no contracts, arrangements, understandings or relationships (legal or otherwise) among the Reporting Person and any other person with respect to any securities of the Issuer, including, but not limited to transfer or voting of any of the securities, finder’s fees, joint ventures, loan or option arrangements, puts or calls, guarantees of profits, division of profits or loss, or the giving or withholding of proxies.

     

    Item 7. Material to be Filed as Exhibits.

     

    99.1   Share Purchase Agreement, dated July 2, 2021, by and between Webao Limited and Hexin Holding Limited

     

    4

     

     

    SIGNATURE

      

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and accurate.

     

      Date: August 2, 2021
         
      Webao Limited
         
      By: /s/ Yunsong Li
      Name: Yunsong Li
      Title: Director

     

     

     

    5

     

     

    Get the next $HX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HX

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $HX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Akso Health Group Announces Effective Date of Name Change and Ticker Symbol Change

    BEIJING, Dec. 16, 2021 /PRNewswire/ -- Akso Health Group ("Akso Health", the "Company" or "We") (NASDAQ:AHG), formerly known as Xiaobai Maimai Inc., today announced that the Company will update its name and ticker symbol on the Nasdaq Stock Market, effective at the start of trading on December 16, 2021 (the "Effective Date"). On the Effective Date, the Company's ADS and ordinary shares will be quoted under the new name "Akso Health Group" which was previously approved by the Company's shareholders (the "Name Change"), and the Company's ticker symbol will be updated to "AHG". Ms. Yilin Wang, Chairwoman and Chief Executive Officer of Akso Health, commented, "We are excited to align our Nasdaq

    12/16/21 6:00:00 AM ET
    $HX
    Finance: Consumer Services
    Finance

    Akso Health Group Reports Unaudited Financial Results for First Half of Fiscal Year 2022

    BEIJING, Dec. 15, 2021 /PRNewswire/ -- Akso Health Group (NASDAQ:AHG) ("Akso Health", the "Company" or "we"), formerly known as Xiaobai Maimai Inc., a social e-commerce platform in China, today announced its unaudited condensed consolidated financial results for the six months ended September 30, 2021. The Company amended the ratio of ADS and ordinary shares from one (1) ADS representing one (1) ordinary share to one (1) ADS representing three (3) ordinary shares, effective as of August 24, 2020. Fiscal year refers to the 12-month period ended March 31. First Half of Fiscal Year 2022 Highlights Number of Average Monthly Mobile Active Users[1] for the six months ended September 30, 2021 was 8

    12/15/21 6:00:00 AM ET
    $HX
    Finance: Consumer Services
    Finance

    Xiaobai Maimai Announces the Results of Annual General Meeting and Name Change

    BEIJING, Dec. 3, 2021 /PRNewswire/ -- Xiaobai Maimai Inc. (NASDAQ:HX) ("Xiaobai Maimai" or the "Company"), today announced that it held the 2021 annual general meeting of shareholders (the "AGM") at the Meeting Room, Futian Shangri-La, 4088 Yi Tian Road, Futian District, Shenzhen 518408, People's Republic of China, at 10:00 a.m. (Beijing Time) on December 3, 2021. At the AGM, holders of 71,057,650 ordinary shares (including ordinary shares represented by the Company's American Depositary Shares), out of the 71,478,550 ordinary shares issued and outstanding, were present in person or by proxy, and therefore constituted a quorum of more than one-third of the ordinary shares outstanding and ent

    12/3/21 4:10:00 PM ET
    $HX
    Finance: Consumer Services
    Finance

    $HX
    SEC Filings

    View All

    SEC Form 424B3 filed by Hexindai Inc.

    424B3 - Xiaobai Maimai Inc. (0001702318) (Filer)

    12/17/21 11:59:56 AM ET
    $HX
    Finance: Consumer Services
    Finance

    SEC Form 6-K filed by Hexindai Inc.

    6-K - Xiaobai Maimai Inc. (0001702318) (Filer)

    12/15/21 8:30:19 AM ET
    $HX
    Finance: Consumer Services
    Finance

    SEC Form 6-K filed by Hexindai Inc.

    6-K - Xiaobai Maimai Inc. (0001702318) (Filer)

    12/7/21 4:30:18 PM ET
    $HX
    Finance: Consumer Services
    Finance

    $HX
    Leadership Updates

    Live Leadership Updates

    View All

    Akso Health Group Reports Unaudited Financial Results for First Half of Fiscal Year 2022

    BEIJING, Dec. 15, 2021 /PRNewswire/ -- Akso Health Group (NASDAQ:AHG) ("Akso Health", the "Company" or "we"), formerly known as Xiaobai Maimai Inc., a social e-commerce platform in China, today announced its unaudited condensed consolidated financial results for the six months ended September 30, 2021. The Company amended the ratio of ADS and ordinary shares from one (1) ADS representing one (1) ordinary share to one (1) ADS representing three (3) ordinary shares, effective as of August 24, 2020. Fiscal year refers to the 12-month period ended March 31. First Half of Fiscal Year 2022 Highlights Number of Average Monthly Mobile Active Users[1] for the six months ended September 30, 2021 was 8

    12/15/21 6:00:00 AM ET
    $HX
    Finance: Consumer Services
    Finance

    Xiaobai Maimai Announces the Results of Annual General Meeting and Name Change

    BEIJING, Dec. 3, 2021 /PRNewswire/ -- Xiaobai Maimai Inc. (NASDAQ:HX) ("Xiaobai Maimai" or the "Company"), today announced that it held the 2021 annual general meeting of shareholders (the "AGM") at the Meeting Room, Futian Shangri-La, 4088 Yi Tian Road, Futian District, Shenzhen 518408, People's Republic of China, at 10:00 a.m. (Beijing Time) on December 3, 2021. At the AGM, holders of 71,057,650 ordinary shares (including ordinary shares represented by the Company's American Depositary Shares), out of the 71,478,550 ordinary shares issued and outstanding, were present in person or by proxy, and therefore constituted a quorum of more than one-third of the ordinary shares outstanding and ent

    12/3/21 4:10:00 PM ET
    $HX
    Finance: Consumer Services
    Finance

    Xiaobai Maimai Appoints Dr. Yingxian Liu as Medical Consultant for We Health Limited

    BEIJING, Oct. 22, 2021 /PRNewswire/ -- Xiaobai Maimai Inc. (NASDAQ:HX) ("Xiaobai Maimai," the "Company," or "we"), today announced the appointment of Dr. Yingxian Liu as the medical consultant to the Company. Dr. Liu will work closely with management to develop the Company's cancer therapy and radiation oncology business by the Company's wholly-owned subsidiary, We Health Limited. Dr. Liu received his medical degree from Sun Yat-sen University of Medical Sciences in Guangzhou, China. He completed his pathology residency at North Shore University Hospital in Manhasset, New York. Dr. Liu completed his hematopathology fellowship at Albert Einstein College of Medicine at Montefiore Medical Cente

    10/22/21 8:00:00 AM ET
    $HX
    Finance: Consumer Services
    Finance

    $HX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D filed by Hexindai Inc.

    SC 13D - Xiaobai Maimai Inc. (0001702318) (Subject)

    8/2/21 4:30:19 PM ET
    $HX
    Finance: Consumer Services
    Finance

    SEC Form SC 13G/A filed by Hexindai Inc. (Amendment)

    SC 13G/A - Xiaobai Maimai Inc. (0001702318) (Subject)

    7/23/21 4:30:21 PM ET
    $HX
    Finance: Consumer Services
    Finance

    SEC Form SC 13G/A filed

    SC 13G/A - Xiaobai Maimai Inc. (0001702318) (Subject)

    2/5/21 7:02:02 AM ET
    $HX
    Finance: Consumer Services
    Finance